走進(jìn)德藥
德州德藥制藥有限公司
地 址：山東省德州市經(jīng)濟(jì)技術(shù)開(kāi)發(fā)區(qū)東方紅東路6000號(hào)
質(zhì)量部：0534-2235805
營(yíng) 銷(xiāo)：0534-2623181 0534-2623132
市場(chǎng)部：0534-2623060
辦公室：0534-2105750
傳 真：0534-2623130
查看手機(jī)官網(wǎng)
頁(yè)面版權(quán)所有? 德州德藥制藥有限公司 魯ICP備11020437號(hào) 互聯(lián)網(wǎng)藥品信息服務(wù)資格證書(shū)編號(hào):（魯）非經(jīng)營(yíng)性-2015-0056 網(wǎng)站建設(shè)：中企動(dòng)力濟(jì)南
ABOUT US
走進(jìn)德藥
德州德藥制藥有限公司前身為山東省德州制藥廠，始建于1971年，是集研發(fā)、生產(chǎn)、銷(xiāo)售于一體的綜合性現(xiàn)代化制藥企業(yè)。
公司于2012年整體搬遷至德州市經(jīng)濟(jì)技術(shù)開(kāi)發(fā)區(qū)，按新版GMP要求建設(shè)德藥新區(qū)，新區(qū)占地面積200畝，建有原料藥到制劑的完備設(shè)備設(shè)施，擁有一支專(zhuān)業(yè)化的研發(fā)、生產(chǎn)、銷(xiāo)售隊(duì)伍。
公司堅(jiān)持走專(zhuān)、精、特、新型企業(yè)發(fā)展之路。專(zhuān)：專(zhuān)注心腦血管、抗腫瘤藥物發(fā)展方向，精：精于緩控釋制劑技術(shù)和凍干制劑技術(shù)，特：要么第一，要么唯一，做全國(guó)銷(xiāo)量第一、全國(guó)唯一的獨(dú)家產(chǎn)品，新：創(chuàng)新發(fā)展，高質(zhì)量發(fā)展。聚焦經(jīng)營(yíng)心腦血管藥、抗腫瘤藥、大品種藥物，三大事業(yè)部形成三足鼎立之勢(shì)，銷(xiāo)售網(wǎng)絡(luò)遍布全國(guó)。
公司擁有雄厚的科技創(chuàng)新能力，是國(guó)家高新技術(shù)企業(yè)、國(guó)家新藥研發(fā)大平臺(tái)示范企業(yè)、省級(jí)企業(yè)技術(shù)中心、藥物滲透泵工程研究中心、博士后創(chuàng)新實(shí)踐基地，德州醫(yī)藥產(chǎn)業(yè)聯(lián)盟龍頭企業(yè)，德州市重點(diǎn)發(fā)展的“護(hù)航”企業(yè)，連續(xù)多年榮獲納稅功勛企業(yè)。
公司堅(jiān)持三個(gè)善待：“善待社會(huì)、善待員工、善待股東”，提高企業(yè)運(yùn)行質(zhì)量，履行社會(huì)責(zé)任，連續(xù)多年被評(píng)為德州市納稅先進(jìn)企業(yè)。董事長(zhǎng)卞建鋼當(dāng)選為山東省人大代表、享受?chē)?guó)務(wù)院特殊津貼。
公司秉承“以德制藥，藥濟(jì)民生”的經(jīng)營(yíng)理念，努力實(shí)現(xiàn)轉(zhuǎn)型升級(jí)，高質(zhì)量發(fā)展，成為政府認(rèn)可、社會(huì)推崇、公眾贊許的優(yōu)秀制藥企業(yè),擔(dān)負(fù)起人類(lèi)治愈疾病、減輕痛苦，提高生活質(zhì)量的使命。爭(zhēng)做行業(yè)百?gòu)?qiáng)，創(chuàng)建百年德藥！
Dezhou Deyao Pharmaceutical Co., Ltd., former Dezhou Pharmaceutical
Factory in Shandong Province, was founded in 1971. It is a comprehensive
modern pharmaceutical enterprise integrating research, production and sales.
In 2012, the company relo cated to Dezhou Economic and Technological
Development Zone. According to the requirements of the new version of GMP,
the new factory covering an area of 200 mu was built. It has complete equipment and facilities from API to preparations, and a specialized R&D, production
and sales team.
The company adheres to the direction of specialized, refined, particular and
innovative enterprise development. Specialty: focus on the development
direction of cardiovascular and cerebrovascular drugs and anti-tumor drugs.
Refining: specialize in the sustained and controlled release preparation
technology and freeze-drying preparation technology. Particular: either the first,
or the unique, to be the first in the national sales volume and the only exclusive
product in the country. Innovation: innovative and high-quality development.
Focusing on the management of cardiovascular and cerebrovascular drugs, anti-tumor drugs, large market volume drugs, the three business
divisions have formed a three-in-one trend and sales network proliferates the country.
The company has strong scientific and technological innovation ability, is the National High-Technology Enterprise, National New Medicine
Research Platform Demonstration Enterprises, Provincial Enterprise Technology Center, Drug Osmotic Pump Engineering Research Center,
Postdoctoral Innovation Practice Base, Dezhou medicine industry leading enterprises alliance, Dezhou key "escort" for the development of
enterprises, and has won the Tax-Paying Meritorious Enterprise for multiple consecutive years.
The company insists on three kinds of treatment: "Treat the society well, treat the employees well and treat the shareholders well". It strives to
improve the operation quality of the enterprise, fulfill the social responsibility , and has been awarded as the Tax-Paying Advanced Enterprise of
Dezhou for multiple consecutive years. Bian Jiangang, chairman of the board with a special allowance from the state council, was elected as a
deputy to the Shandong Provincial People's Congress.
Adhering to the business philosophy of " Make good medicine by our conscience, Improve people's health by our medicine", the company strives
to achieve transformation and upgrading and high-quality development. It has become an excellent pharmaceutical enterprise recognized by the
government, respected by the society and praised by the public. We must undertake the mission of curing diseases, alleviating suffering and
improving the quality of life. The company will undertake the mission of curing diseases, alleviating suffering and improving the quality of life and
strive to become one of the top 100 enterprises in the pharmaceutical industry, make the century dream of Deyao come true.